- Home
- PRLD vs NVRI Comparison
PRLD vs NVRI Comparison
Compare PRLD & NVRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRLD | NVRI |
|---|---|---|
| Founded | 2016 | 1853 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Diversified Commercial Services |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 529.1M | 582.1M |
| IPO Year | 2020 | 2026 |
Fundamental Metrics
Financial Performance| Metric | PRLD | NVRI |
|---|---|---|
| Price | $3.79 | $19.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $9.20 | ★ $28.67 |
| AVG Volume (30 Days) | ★ 395.6K | 242.0K |
| Earning Date | 11-11-2026 | 11-09-2026 |
| Dividend Yield | N/A | ★ 76.81% |
| EPS Growth | ★ 23.21 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $12,140,000.00 | N/A |
| Revenue This Year | $258.83 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 73.43 | N/A |
| 52 Week Low | $1.15 | $11.15 |
| 52 Week High | $6.83 | $24.20 |
Technical Indicators
Market Signals| Indicator | PRLD | NVRI |
|---|---|---|
| Relative Strength Index (RSI) | 32.49 | 39.74 |
| Support Level | $3.40 | $18.92 |
| Resistance Level | $4.10 | $23.68 |
| Average True Range (ATR) | 0.28 | 0.75 |
| MACD | -0.08 | -0.14 |
| Stochastic Oscillator | 11.76 | 28.38 |
Price Performance
Historical ComparisonAbout PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.
About NVRI Enviri Corporation
Enviri Corp provides environmental and operational solutions to the metal and rail industries. It is based in Philadelphia, Pennsylvania, and operates in more than 30 countries. The company leverages industrial expertise to help customers improve operational performance, recover value from byproducts, enhance sustainability, and maintain critical infrastructure. Its divisions are Harsco Environmental and Harsco Rail, which combine deep operational capabilities with technologies and world-wide scale to deliver long-term value for customers, communities, and shareholders.